Literature DB >> 16174543

Reduced cellular immune responses following immunization with a multi-gene HIV-1 vaccine.

Andreas Bråve1, Karl Ljungberg, Andreas Boberg, Erik Rollman, Gunnel Engström, Jorma Hinkula, Britta Wahren.   

Abstract

We investigated the effects of immunizing with several genes and subtypes of HIV-1. The genes used as immunogens were: gp160 envelope (env subtypes A, B and C), p37gag (gag subtypes A and B), rev (subtype B) and reverse transcriptase (RT subtype B). The different genes are all carried by separate plasmids. C57BL/6 and BALB/c mice were immunized with different combinations of the genes together with recombinant cytokine granulocyte macrophage-colony stimulating factor. The env genes injected alone induced significantly stronger cellular responses to envelope in both strains of mice than when env genes were injected together with gag and RT genes. In the C57BL/6 mice, the envelope specific responses were significantly increased after spatial separation of env genes from gag and RT genes as compared to when all vaccine genes were injected as a mixture. The gag responses were strong in gag-immunized animals and were not significantly affected by the spatial separation of gag and RT genes from the env genes. Our results illustrate the importance of being cautious when formulating multivalent genetic vaccines and that it might be possible to overcome lost immune responses through spatial separation of vaccine antigens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174543     DOI: 10.1016/j.vaccine.2005.08.018

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  10 in total

1.  Broad immunogenicity of a multigene, multiclade HIV-1 DNA vaccine boosted with heterologous HIV-1 recombinant modified vaccinia virus Ankara.

Authors:  Eric Sandström; Charlotta Nilsson; Bo Hejdeman; Andreas Bråve; Göran Bratt; Merlin Robb; Josephine Cox; Thomas Vancott; Mary Marovich; Richard Stout; Said Aboud; Muhammad Bakari; Kisali Pallangyo; Karl Ljungberg; Bernard Moss; Patricia Earl; Nelson Michael; Deborah Birx; Fred Mhalu; Britta Wahren; Gunnel Biberfeld
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

2.  Preferential Targeting of Conserved Gag Regions after Vaccination with a Heterologous DNA Prime-Modified Vaccinia Virus Ankara Boost HIV-1 Vaccine Regimen.

Authors:  Asli Bauer; Lilli Podola; Philipp Mann; Marco Missanga; Antelmo Haule; Lwitiho Sudi; Charlotta Nilsson; Bahati Kaluwa; Cornelia Lueer; Maria Mwakatima; Patricia J Munseri; Leonard Maboko; Merlin L Robb; Sodsai Tovanabutra; Gustavo Kijak; Mary Marovich; Sheena McCormack; Sarah Joseph; Eligius Lyamuya; Britta Wahren; Eric Sandström; Gunnel Biberfeld; Michael Hoelscher; Muhammad Bakari; Arne Kroidl; Christof Geldmacher
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

3.  Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania.

Authors:  Muhammad Bakari; Said Aboud; Charlotta Nilsson; Joel Francis; Deus Buma; Candida Moshiro; Eric A Aris; Eligius F Lyamuya; Mohamed Janabi; Karina Godoy-Ramirez; Agricola Joachim; Victoria R Polonis; Andreas Bråve; Patricia Earl; Merlin Robb; Mary Marovich; Britta Wahren; Kisali Pallangyo; Gunnel Biberfeld; Fred Mhalu; Eric Sandström
Journal:  Vaccine       Date:  2011-08-22       Impact factor: 3.641

4.  Increased immunogenicity of a DNA-launched Venezuelan equine encephalitis virus-based replicon DNA vaccine.

Authors:  Karl Ljungberg; Alan C Whitmore; Meagan E Fluet; Timothy P Moran; Reed S Shabman; Martha L Collier; Annette A Kraus; Joseph M Thompson; David C Montefiori; Clayton Beard; Robert E Johnston
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

5.  Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen.

Authors:  Maria L Knudsen; Karl Ljungberg; Roger Tatoud; Jonathan Weber; Mariano Esteban; Peter Liljeström
Journal:  PLoS One       Date:  2015-02-02       Impact factor: 3.240

6.  Therapeutic DNA vaccination of vertically HIV-infected children: report of the first pediatric randomised trial (PEDVAC).

Authors:  Paolo Palma; Maria Luisa Romiti; Carla Montesano; Veronica Santilli; Nadia Mora; Angela Aquilani; Stefania Dispinseri; Hyppolite K Tchidjou; Marco Montano; Lars E Eriksson; Stefania Baldassari; Stefania Bernardi; Gabriella Scarlatti; Britta Wahren; Paolo Rossi
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

7.  Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial.

Authors:  Patricia J Munseri; Arne Kroidl; Charlotta Nilsson; Agricola Joachim; Christof Geldmacher; Philipp Mann; Candida Moshiro; Said Aboud; Eligius Lyamuya; Leonard Maboko; Marco Missanga; Bahati Kaluwa; Sayoki Mfinanga; Lilly Podola; Asli Bauer; Karina Godoy-Ramirez; Mary Marovich; Bernard Moss; Michael Hoelscher; Frances Gotch; Wolfgang Stöhr; Richard Stout; Sheena McCormack; Britta Wahren; Fred Mhalu; Merlin L Robb; Gunnel Biberfeld; Eric Sandström; Muhammad Bakari
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

8.  Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation.

Authors:  Andreas Bråve; Lindvi Gudmundsdotter; Eric Sandström; B Kristian Haller; David Hallengärd; Anna-Karin Maltais; Alan D King; Richard R Stout; Pontus Blomberg; Urban Höglund; Bo Hejdeman; Gunnel Biberfeld; Britta Wahren
Journal:  Vaccine       Date:  2010-10-15       Impact factor: 3.641

9.  Immunotherapy with an HIV-DNA Vaccine in Children and Adults.

Authors:  Paolo Palma; Lindvi Gudmundsdotter; Andrea Finocchi; Lars E Eriksson; Nadia Mora; Veronica Santilli; Angela Aquilani; Emma C Manno; Paola Zangari; Maria Luisa Romiti; Carla Montesano; Alba Grifoni; Andreas Brave; Karl Ljungberg; Pontus Blomberg; Stefania Bernardi; Eric Sandström; Bo Hejdeman; Paolo Rossi; Britta Wahren
Journal:  Vaccines (Basel)       Date:  2014-07-17

10.  HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV.

Authors:  J Hinkula; S Petkov; K Ljungberg; D Hallengärd; A Bråve; M Isaguliants; T Falkeborn; S Sharma; V Liakina; M Robb; M Eller; B Moss; G Biberfeld; E Sandström; C Nilsson; K Markland; P Blomberg; B Wahren
Journal:  Heliyon       Date:  2017-06-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.